Optimising SARS-CoV-2 pooled testing for low-resource settings

Several policy proposals to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been supporting mass individual testing in the USA and other countries.1–3 With restricted testing capacity, such testing is not only infeasible for low-income countries, but also an inefficient use of scarce testing kits that adversely affects the global supply of testing kits.